Amgen Biosimilars

@AmgenBiosim

We’re committed to offering patients broad access to medicines. Follow us to better understand biosimilars. (Community Guidelines: )

Thousand Oaks, CA USA
amgenbiosimilars.com
Geregistreerd in april 2015
328 foto's en video's Foto's en video's

Tweets

Je hebt @AmgenBiosim geblokkeerd

Weet je zeker dat je deze Tweets wilt bekijken? @AmgenBiosim wordt niet gedeblokkeerd door Tweets te bekijken.

  1. 25 jun.

    Amgen’s Laura Sim is speaking about FDA naming considerations for at ACI's Summit on Biosimilars in NYC. If you can’t attend, learn more here:

    2 retweets 3 vind-ik-leuks
    Ongedaan maken
  2. 25 jun.

    ! Can you fill in the blank?

    1 retweet 1 vind-ik-leuk
    Ongedaan maken
  3. 22 jun.

    We were one of the first companies to develop monoclonal antibodies to target diseases with specificity. Learn how we’re leveraging our four decades of experience to continue innovating:

    3 retweets 5 vind-ik-leuks
    Ongedaan maken
  4. 21 jun.

    ! See if you can guess the answer before the timer runs out.

    1 vind-ik-leuk
    Ongedaan maken
  5. 20 jun.

    Our newly redesigned website features everything you need to know about in one place. Discover BioEngage:

    1 retweet 3 vind-ik-leuks
    Ongedaan maken
  6. 19 jun.

    ! What is it called when a pharmacist can dispense an alternative biologic medicine for a prescribed biologic medicine?

    Ongedaan maken
  7. 16 jun.

    The distinguishable suffix used to name products is an important factor in pharmacovigilance. Learn what this means for rheumatologists:

    1 antwoord 1 retweet 2 vind-ik-leuks
    Ongedaan maken
  8. 16 jun.

    Calling all hematologists! We recently redesigned our website to feature everything you need to know about in one place:

    1 vind-ik-leuk
    Ongedaan maken
  9. 16 jun.

    Amgen strives to serve patients by transforming science and biotech into important therapies. Discover more:

    Ongedaan maken
  10. 15 jun.

    What does the power of biosimilars mean for rheumatologists? Take a look:

    1 retweet 2 vind-ik-leuks
    Ongedaan maken
  11. 15 jun.

    Interested in learning more about the power of ? Visit our site:

    1 retweet 1 vind-ik-leuk
    Ongedaan maken
  12. 14 jun.

    Are you attending ? Expand your knowledge of biosimilars and visit our site:

    4 vind-ik-leuks
    Ongedaan maken
  13. 5 jun.

    The distinguishable suffix used to name products is an important factor in pharmacovigilance. Learn what implications it has for oncologists:

    2 antwoorden 4 retweets 5 vind-ik-leuks
    Ongedaan maken
  14. 4 jun.

    Why are suffixes so important when naming and ? Find out:

    2 antwoorden 2 retweets 1 vind-ik-leuk
    Ongedaan maken
  15. 4 jun.

    ’s Richard Markus discussed the promise of in treating cancer at . Learn more:

    11 vind-ik-leuks
    Ongedaan maken
  16. 3 jun.

    Interested in learning more about the power of ? The new BioEngage section of our website will answer all of your questions:

    3 antwoorden 8 retweets 56 vind-ik-leuks
    Ongedaan maken
  17. 3 jun.

    For the past four decades, we’ve combined our knowledge of cancer and to produce cutting-edge therapies. Learn more:

    1 retweet 5 vind-ik-leuks
    Ongedaan maken
  18. 2 jun.

    Calling all attendees! Stop by booth 18043 to test your knowledge & build your own!

    1 antwoord 1 retweet 5 vind-ik-leuks
    Ongedaan maken
  19. 2 jun.

    ! Can you guess the answer before the time runs out?

    1 antwoord 1 retweet 19 vind-ik-leuks
    Ongedaan maken
  20. 1 jun.

    What implications do have on the future of oncology care? Discover the power of on our newly-redesigned website:

    13 retweets 40 vind-ik-leuks
    Ongedaan maken

@AmgenBiosim heeft nog niet getweet.

Het laden lijkt wat langer te duren.

Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.

    Je bent misschien ook geïnteresseerd in

    ·